1 |
Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol. Res. 33: 1-4 (1996)
DOI
ScienceOn
|
2 |
Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol. 93: 123-132 (2004)
DOI
ScienceOn
|
3 |
Raman A, Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine 2: 349-362 (1996)
DOI
ScienceOn
|
4 |
Shetty AK, Kumar S, Sambaiah K, Salimath PV. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocininduced diabetic rats. Plant. Food Hum. Nutr. 60: 109-112 (2005)
DOI
ScienceOn
|
5 |
Day C, Cartwright T, Provost J, Bailey CJ. Hypoglycemic effect of Momordica charantia extracts. Planta Med. 56: 426-429 (1990)
DOI
ScienceOn
|
6 |
Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, Suzuki I. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J. Nutr. Sci. Vitaminol. 47: 340-344 (2001)
DOI
ScienceOn
|
7 |
Rhodes CJ. Type 2 diabetes - a matter of life and death? Science 307: 380-384 (2005)
DOI
|
8 |
Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413 (1997)
DOI
ScienceOn
|
9 |
Yagi N, Yokono K, Amano K, Nagata M, Tsukamoto K, Hasegawa Y, Yoneda R, Okamoto N, Moriyama H, Miki M, Tominaga Y, Miyazaki JI, Yagita H, Okumura K, Mizoguchi A, Miki A, Ide C, Maeda S, Kasuga M. Expression of intercellular adhesion molecule 1 on pancreatic destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 44: 744-752 (1995)
DOI
ScienceOn
|
10 |
Kumar R, Mandal M, Lipton A, Harvey H, Thompson CB. Overexpression of HER2 modulates Bcl-2, , and tamoxifeninduced apoptosis in human MCF-7 breast cancer cells. Clin. Cancer Res. 2: 1215-1219 (1996)
|
11 |
Akhtar MS, Athar MA, Yaqub M. Effect of on blood glucose level of normal and alloxan-diabetic rabbits. Planta Med. 42: 205-212 (1981)
DOI
ScienceOn
|
12 |
Krawinkel MB, Keding GB. Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutr. Rev. 64: 331-337 (2006)
DOI
|
13 |
Kim HY, Kim K. Protective effect of ginseng on cytokine-induced apoptosis in pancreatic . J. Agr. Food Chem. 55: 2816-2823 (2007)
DOI
ScienceOn
|
14 |
Mathis D, Vence L, Benoist C. death during progression to diabetes. Nature 414: 792-798 (2001)
DOI
|
15 |
Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic death in type 1 and type 2 diabetes. Diabetes 54: S97-S107 (2005)
DOI
ScienceOn
|
16 |
Di Matteo MA, Loweth AC, Thomas S, Mabley JG, Morgan NG, Thorpe JR, Green IC. Superoxide, nitric oxide, peroxynitrite, and cytokine combinations all cause functional impairment and morphological changes in rat islets of langerhans and insulinsecreting cell lines but dictate cell death by different mechanism. Apoptosis 2: 164-177 (1997)
DOI
ScienceOn
|
17 |
Miura T, Itoh Y, Iwamoto N, Kato M, Ishida T. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Biol. Pharm. Bull. 2: 248-250 (2004)
|
18 |
Sitasawad SL, Shewade Y, Bhonde R. Role of bittergourd fruit juice in stz-induced diabetic state in vivo and in vitro. J. Ethnopharmacol. 73: 71-79 (2000)
DOI
ScienceOn
|
19 |
Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvessen GS, Dixit VM. , a mammalian homology of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809 (1995)
DOI
ScienceOn
|
20 |
Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK. Antihyperglycemic effects of three extracts from Momordica charantia. J. Ethnopharmacol. 88: 107-111 (2003)
DOI
ScienceOn
|
21 |
Allen RT, Hunter WJ III, Agrawal DW. Morphological and biochemical characterization and analysis of apoptosis. J. Pharmacol. Toxicol. 37: 215-228 (1997)
DOI
ScienceOn
|
22 |
Hui H, Nourparvar A, Zhao X, Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol kinase-dependent pathway. Endocrinology 144: 1444-1455 (2003)
DOI
ScienceOn
|
23 |
Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): A review of efficacy and safety. Am. J. Health Syst. Pharmacol. 60: 356-359 (2003)
|
24 |
Sansome C, Zaika A, Marchenko ND, Moll UT. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. FEBS Lett. 488: 110-115 (2001)
DOI
ScienceOn
|
25 |
Li P-F, Dietz R, Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18: 6027-6036 (1999)
DOI
ScienceOn
|
26 |
Vikrant V, Grover JK, Tandon N, Rathi SS, Gupta N. Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. J. Ethnopharmacol. 76: 139-143 (2001)
DOI
ScienceOn
|
27 |
Wang K, Yin X-M, Cao DT, Milliman CL, Korsmeyer SJ. BID: A novel BH3 domain-only death agonist. Gene Dev. 10: 2859-2869 (1996)
DOI
ScienceOn
|
28 |
Donath MY, Gross DJ, Cerasi E, Kaiser N. Hyperglycemia-induced apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48: 738-744 (1999)
DOI
ScienceOn
|
29 |
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax that accelerates programmed cell death. Cell 74: 609-619 (1993)
DOI
ScienceOn
|
30 |
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489 (1997)
DOI
ScienceOn
|